Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
Eiman Alzaabi, President of the Transfusion Working Group under the Emirates Medical Association and Medical Director of the SEHA Blood Bank, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
”Scientific progress depends on those who choose to share rare observations and challenge assumptions.
Proud to contribute to the transfusion medicine community with this work—and deeply grateful to an outstanding team whose expertise, persistence, and collaboration made it possible. This is what collective science looks like.”
Title: Anti-Ku alloimmunization due to a KEL*02N.19 allele causing Kell-null phenotype despite KEL*02 genotype prediction
Authors: Ravi C. Dara, Rania Madkour, Kathleen Bensing, Eiman Alzaabi, Ihsanullah Sadiq, Nyaradzo Chada, Ghada H. Mawad, Kathleen E. Puca, Manuel Algora
Read the Full Article on Vox Sanguinis.
Stay updated with Hemostasis Today.
-
May 28, 2026, 15:31Spiros Denaxas: National Linked Health Records Reveal Stroke Care Gaps England During and After COVID-19
-
May 28, 2026, 14:21Abdul Mannan: The Hidden Role of Factor XIII in Protecting Clot Stability
-
May 28, 2026, 14:14Spelile Mutupira: Why Hemolysis Remains a Major Laboratory Challenge
-
May 28, 2026, 14:08Fredrick Chalinga: The Science Behind Blood Group Immunogenicity
-
May 28, 2026, 14:00Kalyan Roy: The Critical Role of Chelation Therapy in Thalassaemia
-
May 28, 2026, 13:42Claudio Laudani: Balancing Ischemic and Bleeding Risk in AF with Coronary Disease
-
May 28, 2026, 13:30When it Comes to Stroke Care, Quality Matters – Duke Health
-
May 28, 2026, 13:29Natalie Johnson: Transforming PE Care Through Endovascular Innovation
-
May 28, 2026, 13:16Francisco Chacón-Lozsán: Anticoagulation Strategies for Complex ICU Patients